This rapid, weight-independent improvement in glucose tolerance suggests that disrupting white fat vasculature directly affects metabolic signaling, possibly by interfering with adipokine production or fatty acid metabolism
However, compounded tirzepatide generally costs significantly less than brand-name Mounjaro, which lists at approximately $1,000 to $1,200 per month without insurance coverage
For patients seeing skin laxity alongside fat loss, this stack addresses both processes simultaneously
Typically, IGF-1 LR3 users start with around 20-40 mcg per day, taken 2-3 times a week
Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
